Post by
hoffbag on May 20, 2021 11:11am
financials ok but more to what was unsaid....
Looking through the SEDAR MDA.
Juvente still referred to as a start-up? What is the eventual end game here? Do they have targets? Maybe being in competition with customers is not a good idea but I doubt they perceive Juvente as a threat....more a distraction for Ceapro.
Salaries down. Admin. Didnt want to move? The team has to be growing....not shrinking! Cost management seems good overall though.
I am having difficulty developing an image of Edmonton. Is this a pilot facility or commercial plant? No mention on ramp up...current utilization and target revenue supportable from this operation.
Financials pretty straight forward and as previously discussed on the board except no segmentation (so fine tuning margin details difficult though Proph added).
Need to know where the Golden Gilles is taking us. Example ... $50 million revenue in 5 years? X number of plants? geographic market reach? customer base (target top 5 cosma co's)? Product mix? Gotta stop throwing things against the wall to see what sticks. Invest in the man with a PLAN.
Maybe he has the "strategic vision" but it is of no use unless it is shared and contains some tangible factors. Shareholders like to know where they are being taken (little more detail appreciated) .
Be bold! Kudos for the sales volume up!
Comment by
prophetoffacts on May 20, 2021 12:31pm
This post has been removed in accordance with Community Policy
Comment by
prophetoffacts on May 20, 2021 12:58pm
This post has been removed in accordance with Community Policy
Comment by
lscfa on May 20, 2021 3:09pm
Cash flow no.s cherry picked... cash flow from ops before changes in non-cash working capital is a better indicator. Collecting trade receivables faster this year than last year says nothing about how well the ops generate cash. $989,515 vs. $1,685,353 "Cash generated from operations of $305,000 in Q1 2021 vs. $531,000 in Q1 2020."